Prostate cancer Board decisions

The Veteran's appeal is being remanded due to the need for additional evidence and a VA examination.

The Board denied service connection for prostate enlargement and cancer, finding no evidence of a current disability or association with military service.

The Veteran's claims for service connection for various conditions, including as a result of exposure to herbicides, are being remanded due to incomplete service records and changes in procedures for verifying Agent Orange exposure.

The Board found that the reduction from a 100 percent rating to a 10 percent rating for prostate cancer with prostatectomy, effective April 1, 2007 was in accordance with procedural due process and determined that a 10 percent rating is appropriate based on urinary leakage.

The Veteran's appeal for service connection of prostate cancer has been dismissed due to his death.

The Board denied the appellant's claim to reopen her DIC claim for service connection for the cause of the Veteran's death due to lack of new and material evidence. The Veteran's pancreatic cancer was presumed to be caused by exposure to Agent Orange during service.

The Veteran's back disorder was not incurred in or aggravated by service, and arthritis of the spine may not be presumed to have been so incurred. The Veteran's prostate cancer is not shown to be related to his military service.

The Veteran's claim for an earlier effective date for prostate cancer was denied as the earliest possible effective date is October 18, 2005.

The Board has determined that additional notice is needed and the case is being remanded for further development.

The Veteran's appeal is being remanded for further development, including clarification of prior service and VA examinations to determine the nature and etiology of his claimed disabilities.

The Board denied the Veteran's claim for service connection for prostate cancer, finding no nexus between his claimed in-service asbestos exposure and his current condition. The Board also found that there was no evidence of a disease manifesting within one year of service.

The Board has determined that the Veteran's multiple sclerosis is presumed to have been incurred in service, and he is granted service connection for this condition. The claims for prostate cancer and type II diabetes mellitus are denied as there is no evidence of herbicide exposure during service.

The Board denied the claim for DIC benefits under 38 U.S.C.A. § 1318, finding that the Veteran did not meet the criteria for entitlement to such benefits as he was not rated totally disabled continuously for a period of at least 10 years immediately preceding death.

The Veteran's claim for a total disability rating based on individual unemployability due to service-connected disabilities was granted effective from July 2, 2005. The effective date is earlier than August 19, 2005 as the evidence shows that his full-time employment ended prior to this date.

The Veteran has withdrawn his appeals for increased ratings on depressive disorder and prostate cancer, as well as an earlier effective date for TDIU.

The Veteran's claim for SMC based on the need for regular aid and attendance has been granted due to his service-connected disabilities, which include hypertension with left ventricular hypertrophy and probable old myocardial infarction, depression with cognitive disorder associated with residuals of cerebrovascular accident, prostate cancer with impotence, dermatitis breast and arms, history of hepatitis, and residuals of cerebrovascular accident with right upper extremity hand weakness. The Veteran requires assistance in performing daily activities due to his disabilities.

The Board found that the Veteran's prostate cancer had been effectively treated and no longer required a 100% disability rating, hence reducing it to 40%. The residuals of prostate cancer include urinary incontinence and increased voiding frequency.

The Board has determined that the reduction from a 100% rating to a 40% rating for prostate cancer was proper, effective October 1, 2005. The Veteran is now rated at 60% for residuals of prostate cancer.

The Veteran's claim for an increased rating for prostate cancer residuals was denied. The effective date of the award remains March 25, 2005.

The Board found that the appellant's prostate cancer is not related to his military service, and specifically denied service connection on a direct basis due to lack of evidence of exposure to Agent Orange. The claim was ultimately denied.